BROOKS LABORATORIES Q2 FY27 ; CONS NET PROFIT UP 747.55% AT ₹67.61 CR (YOY), VS LOSS ₹1.79 CR (QOQ)

REVENUE DOWN 17.92% AT ₹19.25 CR (YOY), DOWN 16.17% (QOQ) EBITDA DOWN 43.21% AT ₹1.31 CR (YOY), DOWN 36.24% (QOQ) MARGINS AT 6.81% VS 9.85% (YOY), 8.96% (QOQ)

BROOKS LAB LIMITED

← Back to feed